Live from Advanced Therapies Week! We’re excited to hear Stephen’s thoughts on how the reagent needs of the industry is evolving, and how Teknova can help.
🌟 Advanced Therapies Week Highlight: The Evolution of Bioprocessing Reagents 🌟 Join Stephen Gunstream, President and CEO of Teknova, as he explores the pivotal role of bioprocessing reagents in the development of novel therapies. Hosted by Benjamin McLeod from Convey Bio. Discover how Teknova's modular manufacturing platform enables rapid, scalable, and customizable production of clinical-grade reagents, supporting the unique demands of cell and gene therapy, mRNA, and next-generation antibodies. Learn about their commitment to quality and the critical importance of a versatile manufacturing partner in today’s fast-evolving therapeutic landscape. Tune in to gain strategic insights into accelerating clinical breakthroughs through advanced reagent solutions. #AdvancedTherapiesWeek #ATW25 #AdvancedTherapies #Bioprocessing #Teknova